Matteo Piovella (Italian Society of Ophthalmology, Roma, Italy) discusses the practical benefits the IC-8 small aperture intraocular lens and its mechanism of action, and the major findings of his study, which were presented at the World Ophthalmology Congress 2020.
1. What are the practical benefits of the IC-8 compared with other commercially available IOLs? (0:05)
2. Could you tell us a little about the study you are presenting at the World Ophthalmology Congress 2020 and its major findings? (0:55)
3. Which patients are ideal candidates for IC-8 lens implantation and for whom is it unsuitable? (2:13)
4. What, if any, long-term issues may be anticipated following IC-8 lens implantation? (4:18)
Disclosures: Matteo Piovella has no financial or non-financial relationships or activities to declare in relation to this video.
touchOPHTHALMOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Commissioned, edited and funded by Touch Medical Media
Published: 31 July 2020
